Mielóma multiplex: vizsgálatok itt: Egyesült Államok
297 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleAn AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
- Where
- St Louis
- Életkor
- 18 év to 99 év
- People
- 40
- Run by
- Washington University School of Medicine
See details and how to joinNCT07226934 - No phaseTaking peopleObservational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
- Where
- Houston
- Életkor
- 18 év and over
- People
- 200
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02726750 - No phaseTaking peopleQuality of Life in Patients With Asymptomatic Monoclonal Gammopathies
- Where
- Houston
- Életkor
- 18 év and over
- People
- 400
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05136807 - 2. fázisTaking peopleStudy of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Atlanta, Austin, Baltimore, Birmingham, Boston, Buffalo, Chapel Hill, Charlotte, Chicago, Cincinnati, Columbus, Dallas, Denver, Gilbert, Houston, Iowa City, Jacksonville, Little Rock, Los Angeles, Louisville, Madison, Miami, Nashville, New Brunswick, New York, Norfolk, Philadelphia, Portland, Rochester, Salt Lake City, San Antonio, San Francisco, Seattle, St Louis, Tampa, Westwood
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06297226 - No phaseTaking peopleMoving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
- Where
- Maywood, Milwaukee
- Életkor
- 18 év and over
- People
- 184
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07236502 - 2. fázisTaking peopleInfliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
- Where
- Columbus
- Életkor
- 18 év and over
- People
- 35
- Run by
- Naresh Bumma
See details and how to joinNCT07657312 - 2. fázisTaking peopleLimited-duration Teclistamab
- Where
- Iowa City, Little Rock, New York, Philadelphia
- Életkor
- 18 év and over
- People
- 75
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT05932680 - No phaseTaking peopleA Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Életkor
- 18 év and over
- People
- 200
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06055894 - 1/2. fázisTaking peoplePh I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma
- Where
- Houston
- Életkor
- 18 év to 80 év
- People
- 44
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06066359 - Korai 1. fázisTaking peopleDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Where
- Baltimore
- Életkor
- 18 év and over
- People
- 8
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06398457 - 2. fázisTaking peopleStudy of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
- Where
- Atlanta, Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Életkor
- 18 év and over
- People
- 100
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06976476 - 2. fázisTaking peopleHorizon Two: HR NDMM (MMRC-100)
- Where
- Atlanta, Boston, Chapel Hill, Charlotte, Chicago, Detroit, Duarte, Nashville, New York, Rochester, St Louis
- Életkor
- 18 év and over
- People
- 300
- Run by
- Multiple Myeloma Research Consortium
See details and how to joinNCT07053436 - No phaseTaking peopleUnderstanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
- Where
- Albert Lea, Eau Claire, Jacksonville, La Crosse, Mankato, Rochester, Scottsdale
- Életkor
- 18 év and over
- People
- 82
- Run by
- Mayo Clinic
See details and how to joinNCT06630104 - 2. fázisTaking peopleA Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Életkor
- 60 év and over
- People
- 215
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06679829 - 3. fázisTaking peopleA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Columbus, Fort Wayne, St. Petersburg, Tacoma, Westbrook
- Életkor
- 18 év and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - No phaseTaking peopleRutgers University Study of the Genetics of Blood Cancers
- Where
- Piscataway
- Életkor
- 18 év to 110 év
- People
- 10 000
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT07714044 - 2. fázisTaking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Életkor
- 18 év and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - No phaseTaking peopleSMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
- Where
- Rochester
- Életkor
- 18 év and over
- People
- 150
- Run by
- Mayo Clinic
See details and how to joinNCT07850284 - 3. fázisTaking peopleA Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- Where
- Albany, Atlanta, Austin, Boston, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Coral Gables, Dallas, Denver, Detroit, Gainesville, Gilbert, Houston, Iowa City, Kansas City, La Jolla, Louisville, Madison, Milwaukee, Nashville, New Haven, New York, Park Ridge, Phoenix, Portland, Puyallup, Richmond, Rochester, Sacramento, Salt Lake City, Santa Monica, Seattle, Tampa, The Bronx, Tucson, Washington D.C., Winston-Salem
- Életkor
- 18 év and over
- People
- 508 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07391657 - 2. fázisTaking peopleA Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
- Where
- Cleveland, Denver, Durham, New Haven, New York, Richmond, Rochester, San Francisco, Seattle
- Életkor
- 18 év and over
- People
- 210 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06500884 · EU 2023-506260-14-00 - 1. fázisTaking peopleA Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
- Where
- Atlanta, Charlottesville, Dallas, Denver, Duarte, Houston, Iowa City, Nashville, New York, Phoenix, Rochester, St Louis, Tampa
- Életkor
- 18 év and over
- People
- 40
- Run by
- AstraZeneca
See details and how to joinNCT07073547 - 1/2. fázisTaking peopleA Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
- Where
- Atlanta, Duarte, Houston, Irvine, New York, Scottsdale
- Életkor
- 18 év and over
- People
- 360
- Run by
- Fortvita Biologics (USA)Inc.
See details and how to joinNCT07336472 - 3. fázisTaking peopleA Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Albany, Atlanta, Baltimore, Beverly Hills, Birmingham, Boston, Canton, Chicago, Cincinnati, Dallas, Dayton, Denver, Detroit, Durham, East Brunswick, Eugene, Farmington, Greenville, Indianapolis, Iowa City, Irvine, Jacksonville, Los Angeles, Louisville, Lubbock, Mineola, Minneapolis, Nashville, New York, Omaha, Orange, Pembroke Pines, Phoenix, Rochester, Salt Lake City, Santa Fe, Shirley, Shreveport, Springdale, Tacoma, Waukee
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07518186 - 1. fázisTaking peopleA Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
- Where
- Covington, Dyer, Everett, Houston, Jacksonville, Margate, Ocala, Olympia, Plantation, Springdale, Tamarac
- Életkor
- 18 év and over
- People
- 258 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07477587 - 2. fázisTaking peopleStudy of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
- Where
- Boston, Chicago
- Életkor
- 18 év and over
- People
- 83
- Run by
- University of Chicago
See details and how to joinNCT05789303